Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000451416

Medchemexpress LLC Docosanoic acid | 112-85-6 | 99.4% | 340.59 | 100 G
SDP

Catalog No. 5000451416
Encompass_Preferred

Docosanoic acid (Behenic acid) is a long-chain saturated fatty acid. It inhibits the double-stranded DNA (dsDNA) binding activity of the p53 DNA binding domain, with a Kd of 12 nM. Docosanoic acid has low bioavailability and can increase cholesterol in humans.

  • Effectively inhibits dsDNA binding activity of wild-type p53 DBD with 50% inhibition at 0.41 nmol.
  • Significantly reduces deposition of visceral fat and increases fatty acid excretion in feces in rats.
  • Low bioavailability leads to reduced absorption, contributing to a reduction in body weight and visceral fat deposition.

Catalog No. 50-004-51416 Supplier Medchemexpress LLC Supplier No. HYW013049100G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Docosanoic acid (Behenic acid) is a long-chain saturated fatty acid. It inhibits the double-stranded DNA (dsDNA) binding activity of the p53 DNA binding domain, with a Kd of 12 nM. Docosanoic acid has low bioavailability and can increase cholesterol in humans.

  • Effectively inhibits dsDNA binding activity of wild-type p53 DBD with 50% inhibition at 0.41 nmol.
  • Significantly reduces deposition of visceral fat and increases fatty acid excretion in feces in rats.
  • Low bioavailability leads to reduced absorption, contributing to a reduction in body weight and visceral fat deposition.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.